According to the International Diabetes Federation, 415 million people live with diabetes in the world. This number is expected to grow to more than half a billion in 2040. The increase in diabetes is one of today’s major health challenges –
a global emergency in slow motion. Already today, nearly two-thirds of all people with diabetes live in urban areas. This makes cities an important focal point for tackling diabetes (of which the vast majority is type 2 diabetes).
Novo Nordisk believes a concerted effort is needed and no single organisation or company can solve the challenge alone. Therefore, Novo Nordisk has entered a global partnership with University College London, Steno Diabetes Center, and half a dozen major cities called Cities Changing Diabetes. The aim is to put urban diabetes at the top of the global healthcare agenda and to put it on the agenda of those designing and managing cities for the future.
The programme is shaped through public-private partnerships between businesses, city leaders, city planners, architects, healthcare professionals, academics, community leaders and others with a stake in the outcome. One of the core cities is Shanghai, where the local partnership includes: Shanghai Diabetes Institute, Shanghai Municipal Center for Disease Control and Prevention, and Shanghai Municipal Commission of Health and Family Planning.
Based on the insights from the Cities Changing Diabetes research in Shanghai (will be provided at the event), suggest actions that will help people manage their diabetes and live a healthy life in Shanghai.
The case competition is a 7-hour intensive development process where students will be placed in groups of 5 - 6 people. The groups will be created across different educational backgrounds and be challenged to work together, and ultimately present their best solution to a real and relevant case. Innovation in Action will be held at our Headquarters in Bagsværd, Denmark.
This year, Innovation in Action is going global. There will be one case competition in Denmark and one competition in the US. The best teams from each competition will compete at a finalist event at our headquarters in Bagsværd, Denmark, where they will present their solutions to jury members from top-management.
To apply for participation in Novo Nordisk Innovation in Action case competition you must be enrolled in a master's programme and have a valid student ID. All academic backgrounds, specialisations, nationalities and universities are accepted.
To be selected you must demonstrate that you have a creative and innovative mind-set. This should be done when answering the selected video-recorded question when you apply. You should also upload your CV in English.
In short we are looking for:
Please note that Novo Nordisk covers a maximum of 500 DKK of reimbursement for travel expenses when traveling from outside of Copenhagen.
Curious to learn more about what it is like participating in Novo Nordisk Innovation in Action?
See pictures and videos from previous Novo Nordisk Innovation in Action events in both Aarhus and Copenhagen.
Video from 2014, theme: Recruiting patients for trials in new growth hormone drug development
Video from 2013, theme: Changing Diabetes in Colombia
Video from 2012, theme: Change diabetes in Indonesia through sustainable partnerships
Video from 2012, theme: Reputation Management and Social Media
See pictures from previous events here.
With over 42,000 employees in 77 countries, our culture is as diverse as our geographical spread encouraging an open, honest, respectful, healthy and innovative working environment across national and functional borders.